 similar outcom treatment b-cell t-cell large-cel lymphoma stanford experi previou studi poor prognosi patient peripher t-cell lymphoma clinic signific immunolog phenotyp diffus large-cel lymphoma dlcl controversi patient uniform morpholog diagnosi dlcl stanford cyclophosphamid adriamycin doxorubicin adria columbu OH vincristin prednison chop methotrex bleomycin adriamycin cyclophosphamid vincristin dexamethason bacod methotrex adriamycin cyclophosphamid vincristin prednison bleomycin macop-b chemotherapi regard phenotyp immunolog analysi frozen paraffin-embed tissu case b-cell origin case t-cell origin case b-cell t-cell marker analysi complet remiss CR rate actuari freedom diseas progress actuari overal surviv signific differ prognosi B- t-cell patient actuari surviv patient stage IV t-cell dlcl signific way stage IV b-cell patient treatment select dlcl immunolog phenotyp